Your browser doesn't support javascript.
Characteristics and outcomes of five patients with COVID-19 and hematological malignancies.
Citterio, Chiara; Lazzaro, Antonio; Bosi, Costanza; De Ponzio, Maurice; Cavanna, Luigi.
  • Citterio C; Oncology and Hematology Department Oncology Unit Piacenza General Hospital Piacenza Italy.
  • Lazzaro A; Division of Hematology and Bone Marrow Transplant Center Piacenza General Hospital Piacenza Italy.
  • Bosi C; Division of Hematology and Bone Marrow Transplant Center Piacenza General Hospital Piacenza Italy.
  • De Ponzio M; Pharmacy Unit Piacenza General Hospital Piacenza Italy.
  • Cavanna L; Oncology and Hematology Department Oncology Unit Piacenza General Hospital Piacenza Italy.
Clin Case Rep ; 9(6): e04013, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1263064
ABSTRACT
Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID-19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID-19 can overcome the infection, also in hematological patients.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Clin Case Rep Year: 2021 Document Type: Article